From: MFAP5 promotes basal-like breast cancer progression by activating the EMT program
Sample | NC | MEAP5 | NC + SB431542 | MFAP5 + SB431542 | NC + ly411575 | MFAP5 + ly411575 | |
---|---|---|---|---|---|---|---|
p-Smad2/Smad3 | Gray value | 0 | 302,830 | 0 | 126,610 | 0 | 206,209 |
0 | 246,130 | 0 | 76,568 | 0 | 171,906 | ||
0 | 292,443 | 0 | 79,480.3 | 0 | 186,458 | ||
Average | 0 | 280,468 | 0 | 94,219 | 0 | 188,191 | |
Gray value of each molecule relative to beta-actin (G1) | 0.00 | 0.91 | 0.00 | 0.28 | 0.00 | 0.63 | |
Compared with control group | 0.00 | 0.10 | 0.00 | 0.08 | 0.00 | 0.06 | |
Compared with control group (G1/NC) | 0.00 | 9.29 | 0.00 | 2.89 | 0.00 | 6.51 | |
Internal reference | Gray value | 365,609 | 302,497 | 300,448 | 314,709 | 340,436 | 326,191 |
303,144 | 316,665 | 357,508 | 336,392 | 292,601 | 284,270 | ||
335,737 | 309,839 | 352,063 | 352,295 | 287,281 | 279,450 | ||
Average | 334,830 | 309,667 | 336,673 | 334,465 | 306,773 | 296,637 | |
Compared with control group | 0.09 | 0.02 | 0.09 | 0.06 | 0.10 | 0.09 |